Jack Stewart discusses SOR-C18 leading the phase 1b clinical trial in pancreatic cancer
Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13 is the leading drug in a phase 1b clinical trial in late stage pancreatic cancer. Author: Cancer-News Added: 08/23/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 24, 2019 Category: Cancer & Oncology Source Type: podcasts

Jack Stewart discusses SOR-C18 disruption of TRPV6
Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13, a selective inhibitor of TRPV6, binds with affinity and disrupts how TRPV6 functions. Author: Cancer-News Added: 08/23/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2019 Category: Cancer & Oncology Source Type: podcasts

Jack Stewart discusses SOR-C18 potential in different cancers
Jack Stewart, CSO of Soricimed Biopharma elaborates on how SOR-C18 potentially showing promise in ovarian, metastatic prostate and pancreatic cancer. Author: Cancer-News Added: 08/23/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2019 Category: Cancer & Oncology Source Type: podcasts

Pascal Besman discusses lurbinectedin accelerated approval with FDA
PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Pascal Besman, Pharmamar COO discusses advantages and potential limitations of the new d... Author: PharmaMar Added: 08/22/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Prostate and Kidney Cancer Studies Awaiting Determinnation from FDA
Sarmad Sadeghi, MD, PhD, discusses studies that are awaiting determinations fom the FDA. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

The Need for Nephrectomy
Sarmad Sadeghi, MD, PhD, discusses moving away from the need for Nephrectomy. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Enzamet - Plenary Session / TITAN
Sarmad Sadeghi, MD, PhD, discuses the Enzalutamide and Apalutamide studies. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Alternate Dosing For Immunotherapy
John Freuhauf, M.D., PhD, discusse Lowering Toxicity through alternate dosing. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Will The CheckMate 204 Study Impact Clinicians Today?
John Feuhauf discusses findings of the CheckMate 204 study. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

CheckMate 204 Study
New first line therapy for Asymptomatic Melanoma Brain Metastases. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Could Clinicians Change The Way They Treat Patients
John Freuhauf, M.D., PhD, discusses toxic therapy and how it could change. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Fixing Toxic Therapy
Addressing toxity that causes colitis. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Is INMC Data Practice Changing
John Freuhauf, M.D., PhD, discusses practice changing data from INMC. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

How Data form INMC Has Impacted Surgical Oncologists
Johan Freufauf, M.D., PhD, discusses findings form the INMC. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

International Neoadjuvant Melanoma Consortium
John Fruehauf, M.D., PhD,discusses the International Neoadjuvant Melanoma Consortuim. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Other Prognastic Factors of The IDEA Collaboration
Afsaneh Barzi, M.D., discusses other prognastic factors of the IDEA collaboration. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

The impact the IDEA data will have on clinicians
Afsaneh Barzi, M.D., discusses the impact the the IDEA data will have on clinicians today. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

3 Vs. 6 months of Adjuvant for Stage 3 Colon Cancer
Afsaneh Barzi, M.D., discusses 3 months Vs. 6 months of Adjuvant for Colon Cancer. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

IDEA Collaboration
Afsaneh Barzi, M.D., discusses the International Duration Evaluation of Adjuvant Chemotherapy. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Immediate Implications of the POLO study.
POLO trial for advanced pancreatic cancer: a new standard of care. Treatment with the drug olaparib significantly reduced the risk of disease progression or death from metastatic pancreatic cancer, Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Unanswered questions after the POLO study
POLO trial for advanced pancreatic cancer: a new standard of care. Treatment with the drug olaparib significantly reduced the risk of disease progression or death from metastatic pancreatic cancer, Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

POLO Study
Maintenance therapy for BRCA mutants. Author: Annual-Meeting Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Taofeek Owonikoko, MD Discusses lurbinectedin as a Potential Practice Changing in SCLC Treatment
Lurbinectedin, a potential practice changing drug if approved, will be the only agent available in SCLC tested with immunotherapy. PharmaMar to submit New Drug Application (NDA) for lurbinectedin unde... Author: PharmaMar Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Pharmamar-Taofeek Owonikoko
Author: PharmaMar Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Hossein Borghaei, MD discusses lurbinectedin recent data and advantages and potential limitations of the new drug
PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD discusses the recent data released and advantages and potential lim... Author: PharmaMar Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Hossein Borghaei, MD of Fox Chase Discusses new data on lurbinectedin
PharmaMar will submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD of Fox Chase discusses the new data released and what advantages ... Author: PharmaMar Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma - What is the role of MRD in MM
Author: cancergrace Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma - What are the novel new antibodies for MM therapy
Author: cancergrace Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma - Should everyone receive an autologous transplant
Author: cancergrace Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma - Is there a preferred induction therapy
Author: cancergrace Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts

Lymphoma - What is the role of diagnostic testingcytogenetics in 2016
Lymphoma - What is the role of diagnostic testing cytogenetics in 2016 Author: cancergrace Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts

Lymphoma - Is there still a role for chemo
Author: cancergrace Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts

SampleVideo_1280x720_1mb
test Author: rajkumar Added: 08/05/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2019 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma - What is the role of MRD in MM
Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2019 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma - What are the novel new antibodies for MM therapy
Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2019 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma - Should everyone receive an autologous transplant
Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2019 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma - Is there a preferred induction therapy
Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2019 Category: Cancer & Oncology Source Type: podcasts

Lymphoma - What is the role of diagnostic testingcytogenetics in 2016
Lymphoma - What is the role of diagnostic testing cytogenetics in 2016 Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2019 Category: Cancer & Oncology Source Type: podcasts

Lymphoma - Is there still a role for chemo
Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2019 Category: Cancer & Oncology Source Type: podcasts

ALL: Measurable Residual Disease - What Can Physicians Do with MRD Information
Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2019 Category: Cancer & Oncology Source Type: podcasts

ALL: Measurable Residual Disease - When Should they Test MRD and How do they get MRD from Patients
Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2019 Category: Cancer & Oncology Source Type: podcasts

All: Measurable Residual Disease - What Tests Used How do They Work and Which is Best for the Patient
Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2019 Category: Cancer & Oncology Source Type: podcasts

ALL: Measurable Residual Disease - What is MRD and Why is it Important
Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2019 Category: Cancer & Oncology Source Type: podcasts

ALL: Measurable Residual Disease - What does it mean to be MRD Positive
Measurable Residual Disease - ALL: What does it mean to be MRD Positive Author: cancergrace Added: 07/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2019 Category: Cancer & Oncology Source Type: podcasts

CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
Earn CME: https://naccme.com/program/...In this presentation from the 'Keeping Up With CAR T-cell Therapies in B-Cell Lymphomas' symposium at the 2019 Great Debates & Updates in Hematologic M... Author: imedex Added: 07/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Update: Relapsed/Refractory Follicular Lymphoma
Earn CME: https://www.naccme.com/prog...In this presentation from the 'Persistent Challenges in the Management of Follicular Lymphoma' symposium at the 2019 Great Debates & Updates in Hem... Author: imedex Added: 07/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 2, 2019 Category: Cancer & Oncology Source Type: podcasts